Article Access statistics

Viewed: 71

Emailed: 0

PDF Downloaded: 51

IP Indian Journal of Clinical and Experimental Dermatology

Safety and efficacy of skimune tablet and gel with respect to psoriasis

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Nimish Vador*, Bhavesh Vador

Volume : 6, Issue : 1, Year : 2020

Article Page : 1-4

Suggest article by email


Psoriasis is an autoimmune disorder. It is characterized by chronic inflammatory condition of skin. It
leads to thick, scaly plaques on skin . Current medication involves symptomatic treatment by the various
moisturizers, however, the effects do not last long and recurrence occurs. Based on several ancient text
a combination of herbs was formulated and named as Skimune tablet and Gel. Preclinical safety was
conducted which was found to be safe for the dose above 5000 mg/kg of body weight. The beneficial
effects of Skimune Tablet and Gel was clinically evaluated on patients with mild to moderate psoriasis. The
Dermatology Life Quality Index (DLQI) and Psoriasis area & severity index (PASI) score was evaluated to
understand the effects of tablet and Gel. Skimune tablet was found to be safe upto 5000mg/kg of body
weight in animals and was well tolerated in patients too. Skimune Tablet and Gel showed significant
improvement (P <0>

Keywords: Skimune, Psoriasis, Ayurveda, Inflammation, Chronic.

Doi : 10.18231/j.ijced.2020.001

How to cite : Vador N , Vador B, Safety and efficacy of skimune tablet and gel with respect to psoriasis. IP Indian J Clin Exp Dermatol 2020;6(1):1-4

Copyright © 2020 by author(s) and IP Indian J Clin Exp Dermatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (